These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10814873)

  • 1. Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia.
    Nasir L; Krasner H; Argyle DJ; Williams A
    Cancer Lett; 2000 Jul; 155(1):1-7. PubMed ID: 10814873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
    Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
    J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of retinoblastoma protein, but not p53, is associated with the presence of papillomaviral DNA in feline viral plaques, Bowenoid in situ carcinomas, and squamous cell carcinomas.
    Munday JS; Aberdein D
    Vet Pathol; 2012 May; 49(3):538-45. PubMed ID: 21930804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours.
    Inoue M; Shiramizu K
    J Comp Pathol; 1999 Feb; 120(2):169-75. PubMed ID: 10087490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhematopoietic neoplasms in cats.
    Patnaik AK; Liu SK; Hurvitz AI; McClelland AJ
    J Natl Cancer Inst; 1975 Apr; 54(4):855-60. PubMed ID: 1055268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of p53 in animal tumors: a methodological study using four anti-human p53 antibodies.
    Albaric O; Bret L; Amardeihl M; Delverdier M
    Histol Histopathol; 2001 Jan; 16(1):113-21. PubMed ID: 11193185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs.
    Teifke JP; Löhr CV
    J Comp Pathol; 1996 Feb; 114(2):205-10. PubMed ID: 8920221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
    Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
    Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma.
    Mayr B; Reifinger M; Loupal G
    Vet J; 1998 Jan; 155(1):103-6. PubMed ID: 9455165
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors.
    Nakano M; Wu H; Taura Y; Inoue M
    J Vet Med Sci; 2006 May; 68(5):421-5. PubMed ID: 16757883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of p53 mutations in feline neoplasms.
    Mayr B; Blauensteiner J; Edlinger A; Reifinger M; Alton K; Schaffner G; Brem G
    Res Vet Sci; 2000 Feb; 68(1):63-70. PubMed ID: 10684760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms.
    Beam SL; Rassnick KM; Moore AS; McDonough SP
    Vet Pathol; 2003 Sep; 40(5):496-500. PubMed ID: 12949405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical distribution pattern of intermediate filament proteins in 50 feline neoplasms.
    Martín de las Mulas J; Espinosa de los Monteros A; Carrasco L; van Niel M; Fernández A
    Vet Pathol; 1995 Nov; 32(6):692-701. PubMed ID: 8592805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of neoplasia in domestic animals.
    Owen LN
    Adv Vet Sci Comp Med; 1976; 20():223-52. PubMed ID: 188328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
    Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
    Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.